Laverock Therapeutics raises £13.5m to accelerate gene silencing platform
Laverock Therapeutics, the gene editing-induced gene silencing platform for human therapeutic applications, has expanded its seed funding round to £13.5 million.
Stay updated with breaking news from Seed Financing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Laverock Therapeutics, the gene editing-induced gene silencing platform for human therapeutic applications, has expanded its seed funding round to £13.5 million.
Mural Health Technologies, Inc. has raised $8 million in seed funding for the growth of its Mural link platform it says is aimed at ‘modernizing the clinical trial experience for both patients and caregivers’.
Science On Call Raises $2.6 Million in Seed Financing to Transform ...
Lesotho: Prime Minister Launches Entrepreneurship Hub
The Life Science startup DNTOX receives seed funding of €1.4 million. The round is led by HTGF, with private investors Barbara Korte-Sturm and Nikolaus Sturm as well as Bool Capital and AQAL Capit ...